Beta Interferon - Articles

Sort by: Newest Most Comments Relevance

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis by stuart Patient Expert

Posted Wed 14 Jan 2009 8:24pm Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis PubMed - 2008 Jun 4. [Epub ahead of print] Birnbaum G, Cree B... be administered safely to persons with relapsing remitting multiple sclerosis (MS) taking thrice weekly, 44 mcg dose subcutaneous interferon beta-1a. » Read More - Read on »

Is Interferon Beta-1b For Secondary Progressive Multiple Sclerosis? by Jughead Patient Expert

Posted Wed 06 Oct 2010 12:00am Having a hard time figuring out if Novantrone is the same as Interferon beta-1b? I see on the National MS page they're not, but I thought I took them all. Beta-1b says it's for SPMS, I think? Has anyone been told it's for SPMS ? I can see I need to get back on top of my terms and figure out what I have again, it's the only to be informed Read on »

Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis by stuart Patient Expert

Posted Wed 10 Feb 2010 12:00am February 8, 2010 Objectives To confirm that neutralizing antibodies (NAb) to interferon beta can persist after therapy withdrawal and to evaluate whether persisting NAb... of 71 patients with relapsing-remitting multiple sclerosis treated with interferon beta in the past. Main Outcome Measures Persisting NAb after therapy withdrawal were tested Read on »

Daclizumab May Reduce MS Disease Activity More Than Interferon Beta Alone by stuart Patient Expert

Posted Tue 16 Feb 2010 12:00am DG NEWS NEW YORK -- February 15, 2010 -- Add-on daclizumab treatment might reduce multiple sclerosis disease activity more than standard interferon beta treatment... whether daclizumab reduces disease activity in patients with active relapsing multiple sclerosis who are receiving standard interferon beta treatment. Click here to continue Read on »

The REGARD Study – A Head-to-Head Comparison of Rebif®® (glatiramer acetate) 44 mcg (interferon beta-1a) and Copax by stuart Patient Expert

Posted Thu 15 Jan 2009 7:22pm Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). The REGARD study compared Rebif (interferon beta-1a) 44 mcg and Copaxone (glatiramer acetate) over 96 weeks... interferon-beta and glatiramer acetate. The interferon-beta preparation used in the study was Rebif, and the study was sponsored by EMD Serono and Pfizer, co-marketers of Rebif Read on »

Biogen Idec Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multipl by stuart Patient Expert

Posted Mon 22 Jun 2009 12:21pm designed to evaluate the efficacy and safety of PEGylated interferon beta-1a (BIIB017) in patients with relapsing multiple sclerosis (RMS). The trial, called ADVANCE, will determine the efficacy of PEGylated interferon beta-1a in reducing relapse rates in patients with RMS. “A major issue with patient adherence to injectable therapies Read on »

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis by stuart Patient Expert

Posted Wed 23 Sep 2009 10:39pm Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension.... Following this, a period of slow progression of disability may appear. Interferon (IFN) beta is one of the accepted drugs for MS, as it has been proven to reduce the relapse rate Read on »

Merck Serono Launches New Formulation Of Interferon Beta-1a by stuart Patient Expert

Posted Wed 14 Jan 2009 8:26pm Medical News Today Article Date: 03 Mar 2008 - 12:00 PST Merck Serono, a division of Merck KGaA, has announced that Rebif® New Formulation (interferon beta... OL, Casset-Semanaz F, et al. on behalf of the RNF Study Group Safety and immunogenicity of interferon beta-1a (Rebif® New Formulation) in a phase IIIb study in patients Read on »

Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical by stuart Patient Expert

Posted Tue 26 Oct 2010 12:00am the efficacy and safety of two doses of once daily teriflunomide (7mg or 14mg) versus placebo in patients with relapsing multiple sclerosis (RMS) treated with interferon beta (IFN beta... effect observed when it was used in adjunct with interferon beta in the Phase II study." Specifically, the TERACLES study will evaluate whether once daily oral teriflunomide 14 Read on »

MS eJournal Club's webcast on interferon beta-1b versus 20 mg glatiramer acetate - Taking place on December 2, 2009 by stuart Patient Expert

Posted Mon 30 Nov 2009 10:20pm µg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study."After the live discussion Read on »